| 5-Aza-dC | 5-aza-2′-deoxycytidine |
| 5hmC | 5-hydroxymethylcytosine |
| 5mC | 5-methylcytosine |
| AD | Atopic dermatitis |
| APE1 | Apurinic endonuclease 1 |
| BET | Bromodomain and extra- terminal |
| BRD | Bromodomain |
| circRNA | Circular RNA |
| CLP | Cutaneous lichen planus |
| COL1A1 | Collagen type I alpha 1 chain |
| CpG | Cytosine-guanine |
| CXCL13 | C-X-C motif chemokine ligand 13 |
| DEHP | Di-(2-ethylhexyl) phthalate |
| DLL4 | Delta-like ligand 4 |
| DNCB | 2,4-dinitrochlorobenzene |
| DNFB | 2,4-dinitrofluorobenzene |
| DNMT | DNA methyltransferase |
| DZNep | 3-deazaneplanocin |
| EZH2 | Enhancer of zeste homolog 2 |
| FNA | Functional nucleic acid |
| H3K27me3 | H3K27 trimethylation |
| H3K9ac | Histone H3 lysine-9 acetylation |
| HATs | Histone acetyltransferases |
| HDAC | Histone deacetylase |
| HO-1 | Heme-oxygenase 1 |
| IL | Interleukin |
| IMQ | Imiquimod |
| iNOS | Inducible nitric oxide synthase |
| LE | Lupus erythematosus |
| lncRNA | Long non-coding RNA |
| LP | Lichen planus |
| LPS | Lipopolysaccharide |
| miRNA | MicroRNA |
| ncRNA | Non-coding RNA |
| NF-κB | Nuclear factor kappa-light-chain enhancer of activated B cells |
| NK | Natural killer |
| NRF2 | Nuclear factor erythroid 2-related factor 2 |
| OLP | Oral lichen planus |
| PASI | Psoriasis area and severity index |
| PBMCs | Peripheral blood mononuclear cells |
| PRC | Polycomb repressive complex |
| PRF1 | Perforin 1 |
| PTMs | Post-translational modifications |
| RORC | RAR-related orphan receptor C |
| siRNA | Small interfering RNA |
| SIRT1 | Sirtuin 1 |
| SLE | Systemic lupus erythematosus |
| SSc | Systemic sclerosis |
| STAT3 | Suppressing signal transducer and activator of transcription 3 |
| TET | Ten-eleven translocation |
| TGF-β | Transforming growth factor beta |
| Th17 | T helper 17 cells |
| TNF | Tumor necrosis factor |
| TSA | Trichostatin A |
| TubA | Tubastatin A |
| UTRs | Untranslated regions |
| VDR | Vitamin D receptor |
| XRCC1 | X-ray repair cross-complementing protein 1 |